Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 38Pancreatic Neoplasms 21Stomach Neoplasms 16Colonic Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 11Adenocarcinoma Of Esophagus 11Rectal Neoplasms 10Neoplasm Metastasis 10Esophageal Neoplasms 10Neoplasms 9Cholangiocarcinoma 6Adenocarcinoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Esophageal Squamous Cell Carcinoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Advanced Solid Tumors 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia 2Down Syndrome 2

Interventions

fludarabine 6Cyclophosphamide 5fludarabine phosphate 4Melphalan 3Busulfan 3trametinib 2thymoglobulin 2Whole-Body Irradiation 2Tacrolimus 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Cytarabine 2Biopsy 2omipalisib 1merphos 1imetelstat 1hydrocortisone hemisuccinate 1blinatumomab 1Transplantation 1Thiotepa 1Spinal Puncture 1Sirolimus 1Rituximab 1Radiotherapy 1Mesna 1Levetiracetam 1Leucovorin 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Juvenile × Leucovorin × 90 days × Clear all
NCT06247787 2026-04-20

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Children's Oncology Group

Phase 1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡